Medical News

RSS

Re-classification of cannabis will have minimal impact on incidence of psychosis says study

The research follows last year’s decision by the UK government to reclassify the drug from class C to class B, partly out of concerns that cannabis, especially the more potent varieties, may increase the risk of schizophrenia in young people. However, the evidence for the relationship between cannabis and schizophrenia or psychosis remains controversial.

5 Nov 2009

Nanoparticles may cause DNA damage across a cellular barrier

Scientists have shown in the laboratory that metal nanoparticles damaged the DNA in cells on the other side of a cellular barrier. The nanoparticles did not cause the damage by passing through the barrier, but generated signalling molecules within the barrier cells that were then transmitted to cause damage in cells the other side of the barrier.

5 Nov 2009

FDA grants Abraxis BioScience orphan drug designation for ABRAXANE

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation to the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the treatment of pancreatic cancer as well as stage IIB-IV melanoma.

5 Nov 2009

General Nutrition Centers announces financial results for the third quarter of 2009

General Nutrition Centers, Inc., a leading global specialty retailer of nutritional products, today reported its financial results for the quarter ended September 30, 2009.

5 Nov 2009

NxStage Medical reports strong results for the third quarter of 2009

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today posted strong third quarter results.

5 Nov 2009

ARIAD Pharmaceuticals' SUCCEED trial of oral ridaforolimus on track

ARIAD Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009 and provided an update on corporate developments.

5 Nov 2009

New biosensor device may help in combating cancer

A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters.

5 Nov 2009

IntegraMed America reports operating results for the third quarter of 2009

IntegraMed America, Inc., the nation’s leading manager of specialty outpatient healthcare facilities in the emerging, technology-focused medical niches of fertility and vein care, today reported improved overall operating results for the third quarter and nine months ended September 30, 2009.

5 Nov 2009

Oncolytics Biotech reports financial results for the third quarter of 2009

Oncolytics Biotech Inc. today announced its financial results for the three and nine-month periods ended September 30, 2009.

5 Nov 2009

LaserBand signs an agreement for healthcare wristbands and labels with MedAssets Supply Chain Systems

LaserBand, the leading provider of patient identification wristbands and related products, recently signed an agreement for healthcare wristbands and labels with MedAssets Supply Chain Systems, one of the nation’s largest group purchasing organizations (GPO).

5 Nov 2009

Home Diagnostics announces financial results for third quarter 2009; reports decreased gross margin

Home Diagnostics, Inc. (Nasdaq:HDIX), a leading manufacturer and marketer of diabetes testing supplies, today announced financial results for the third quarter ended September 30, 2009.

5 Nov 2009

Sonomax U.K. to supply SonoCustom earplugs to DFRMO

Sonomax UK Limited reports that working for extended periods on military airfields and in close proximity to fast jet aircraft with a typical noise exposure of between 110 and 140 decibels, the United Kingdom Ministry of Defence Fire Risk Management Organization (DFRMO) recognized the need to review the hearing protection being supplied to their fire fighters.

5 Nov 2009

I-Flow reports financial results for the third quarter of 2009

I-FLOW CORPORATION announced today that total revenue for the third quarter ended September 30, 2009 increased 14% to $36.7 million compared to total revenue of $32.2 million for the third quarter of 2008.

5 Nov 2009

Third-quarter financial results for the year 2009 announced by Biovail

Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company’s current views, and actual outcomes are not certain.

5 Nov 2009

Dietary options and better detection improve food allergy management procedures

Less restrictive dietary options, better detection, targeted avoidance measures, educational directives and potential new therapies are improving food allergy management and giving hope to the more than 12 million Americans affected according to experts at the thirteenth international food allergy conference held during the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

5 Nov 2009